Literature DB >> 19159963

[Congenital retinocephalic facial vascular malformation syndrome. Bonnet-Dechaume-Blanc syndrome or Wyburn-Mason syndrome].

D Schmidt1.   

Abstract

The congenital retinocephalic facial vascular malformation syndrome is characterized by unilateral, nonhereditary retinal and cerebral arteriovenous malformations (AVMs) and is occasionally associated with orbital vascular changes. Typical signs are facial and oral mucosal vascular changes, rarely with changes of the maxilla or mandible. An AVM causes high blood flow because of direct connection (shunting) of major vessels without interposition of capillaries. Ocular complications include retinal and vitreous hemorrhages, edema, venous occlusion (risk of rubeosis iridis and secondary glaucoma). Neuroophthalmological changes comprise optic atrophy, papilledema, proptosis, pupillary changes, hemianopia, gaze paresis, nystagmus, cranial nerve palsies, strabismus, and amblyopia. Neurological complications include headache, subarachnoid hemorrhage, convulsions, cerebral hemorrhages, increased intracranial pressure, hydrocephalus, and stroke with hemiparesis. Threatening oral hemorrhages or epistaxis may rarely occur.

Entities:  

Mesh:

Year:  2009        PMID: 19159963     DOI: 10.1007/s00347-008-1893-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  17 in total

1.  Spontaneous involution of retinal and intracranial arteriovenous malformation in Bonnet-Dechaume-Blanc syndrome.

Authors:  M C Brodsky; W F Hoyt
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  Functional and anatomical investigations in racemose haemangioma.

Authors:  Carsten H Meyer; Eduardo B Rodrigues; Stefan Mennel; Volker Klingmüller; Peter Kroll
Journal:  Acta Ophthalmol Scand       Date:  2007-08-17

3.  Wyburn-Mason syndrome: report of a rare case with computed tomography and angiographic evaluations.

Authors:  K Kikuchi; M Kowada; T Sakamoto; Y Tamakawa; S Sakuragi
Journal:  J Comput Tomogr       Date:  1988-04

4.  Wyburn-Mason syndrome--a case report.

Authors:  P H Tchen; C J Yan; H M Lo; K M Huang
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1985-11

5.  Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification.

Authors:  J J Bhattacharya; C B Luo; D C Suh; H Alvarez; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

6.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

7.  Fibrotic racemose haemangioma of the retina.

Authors:  P B Knecht; M M Bosch; H Helbig
Journal:  Klin Monbl Augenheilkd       Date:  2008-05       Impact factor: 0.700

8.  Bilateral Wyburn-Mason syndrome presenting as acute subarachnoid haemorrhage - a very rare congenital neurocutaneous [corrected] disorder.

Authors:  S O S Cortnum; P Sørensen; J Andresen
Journal:  Acta Neurochir (Wien)       Date:  2008-06-12       Impact factor: 2.216

Review 9.  The congenital unilateral retinocephalic vascular malformation syndrome (bonnet-dechaume-blanc syndrome or wyburn-mason syndrome): review of the literature.

Authors:  Dieter Schmidt; Mona Pache; Martin Schumacher
Journal:  Surv Ophthalmol       Date:  2008 May-Jun       Impact factor: 6.048

Review 10.  Ocular complications of arteriovenous communications of the retina.

Authors:  A M Mansour; C G Wells; L M Jampol; R E Kalina
Journal:  Arch Ophthalmol       Date:  1989-02
View more
  2 in total

1.  [Retinal arteriovenous malformation].

Authors:  D Finis; J Stammen
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

2.  The Natural History of Retinal Vascular Changes from Infancy to Adulthood in Wyburn-Mason Syndrome.

Authors:  Kristina Horkovicova; Ivajlo Popov; Dana Tomcikova; Veronika Popova; Vladimir Krasnik
Journal:  Medicina (Kaunas)       Date:  2020-11-09       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.